[1]刘雨平,罗佐杰.促甲状腺激素受体在非甲状腺组织中的表达及意义[J].国际内分泌代谢杂志,2021,41(01):10-14.[doi:10.3760/cma.j.cn121383-20200509-05015]
　Liu Yuping,Luo Zuojie..Expression and significance of thyroid stimulating hormone receptor in extrathyroidal tissues[J].International Journal of Endocrinology and Metabolism,2021,41(01):10-14.[doi:10.3760/cma.j.cn121383-20200509-05015]
点击复制

促甲状腺激素受体在非甲状腺组织中的表达及意义()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年01期
页码:
10-14
栏目:
甲状腺疾病专题
出版日期:
2021-01-20

文章信息/Info

Title:
Expression and significance of thyroid stimulating hormone receptor in extrathyroidal tissues
作者:
刘雨平; 罗佐杰
广西医科大学第一附属医院内分泌科,南宁 530021
Author(s):
Liu Yuping;  Luo Zuojie.
Department of Endocrinology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
关键词:
促甲状腺激素受体;  脑组织;  脂肪组织;  肝脏;  骨骼
Keywords:
Thyroid stimulating hormone receptor;  Brain tissue;  Adipose tissue;  Liver;  Bone
DOI:
10.3760/cma.j.cn121383-20200509-05015
摘要:
促甲状腺激素受体(thyroid stimulating hormone receptor,TSHR)可在多种非甲状腺组织中表达,通过激活不同的信号通路产生不同的作用。在脑组织表达的TSHR是自身免疫性甲状腺病与精神疾病之间相联系的关键; 在心肌表达的TSHR与甲状腺功能减退性心力衰竭有关; 在脂肪组织表达的TSHR与Graves眼病、肥胖、胰岛素分泌异常的发生、发展有关; 在肝脏表达的TSHR参与了糖、脂代谢的调控; 在骨组织表达的TSHR则主要参与骨代谢的调控,对于防治骨质疏松的发生、发展具有重要作用。因此,探讨TSHR在不同组织中的表达及其作用机制对于防治心脑血管疾病和内分泌代谢性疾病等具有重要的意义。
Abstract:
Thyroid stimulating hormone receptor(TSHR)can be expressed in a variety of non-thyroid tissues and plays different roles by activating different signaling pathways. TSHR expressed in brain tissue may be a key target for the link between autoimmune thyroid disease and mental disease. TSHR expressed in myocardium may be related to heart failure in hypothyroidism. TSHR expressed in adipose tissue is related to the occurrence and development of Graves' ophthalmopathy, obesity and abnormal insulin secretion. TSHR expressed in liver is involved in the regulation of glucose and lipid metabolism. TSHR expressed in bone tissue is mainly involved in the regulation of bone metabolism, which plays an important role in preventing the occurrence and development of osteoporosis. Therefore, exploring the expression of TSHR in different tissues and its mechanism have important guiding significance for the prevention and treatment of heart diseases, brain diseases, endocrine and metabolic diseases.

参考文献/References:

[1] Prummel MF,Brokken LJ,Meduri G,et al. Expression of the thyroid-stimulating hormone receptor in the folliculo-stellate cells of the human anterior pituitary[J].J Clin Endocrinol Metab,2000,85(11):4347-4353.DOI:10.1210/jcem.85.11.6991.
[2] Naicker M,Naidoo S. Expression of thyroid-stimulating hormone receptors and thyroglobulin in limbic regions in the adult human brain[J].Metabolic Brain Dis,2017,33(2):481-489.DOI:10.1007/s11011-017-0076-3.
[3] Naicker M,Abbai N,Naidoo S. Bipolar limbic expression of auto-immune thyroid targets: thyroglobulin and thyroid-stimulating hormone receptor[J].Metab Brain Dis,2019,34(5):1281-1298.DOI:10.1007/s11011-019-00437-w.
[4] Chen J,Shi M,Wang N,et al. TSH inhibits eNOS expression in HMEC-1 cells through the TSHR/PI3K/AKT signaling pathway[J].Ann Endocrinol(Paris),2019,80(5-6):273-279.DOI:10.1016/j.ando.2019.06.007.
[5] Liu X,Du H,Chai Q,et al. Blocking mitochondrial cyclophilin D ameliorates TSH-impaired defensive barrier of artery[J].Redox Biol,2018,15:418-434.DOI:10.1016/j.redox.2018.01.004.
[6] Woeller CF,Roztocil E,Hammond C,et al. TSHR signaling stimulates proliferation through PI3K/Akt and induction of miR-146a and miR-155 in thyroid eye disease orbital fibroblasts[J].Invest Ophthalmol Vis Sci,2019,60(13):4336-4345.DOI:10.1167/iovs.19-27865.
[7] 孟淑华,魏军平. TSHR信号转导通路在Graves眼病发病机制中的作用[J].国际内分泌代谢杂志,2014,34(02):84-86.DOI:10.3760/cma.j.issn.1673-4157.2014.02.004.
[8] Ma S,Jing F,Xu C,et al. Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3[J].Sci Rep,2015,5:7633.DOI:10.1038/srep07633.
[9] Zhou LY,Wu KP,Zhang LY,et al. Liver-specific deletion of TSHR inhibits hepatic lipid accumulation in mice[J].Biochem Biophys Res Commun,2018,497(1):39-45.DOI:10.1016/j.bbrc.2018.01.187.
[10] Li YJ,Wang LC,Zhou LY,et al. Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2[J].Mol Cell Endocrinol,2017,446:70-80.DOI:10.1016/j.mce.2017.02.015.
[11] Slominski A,Wortsman J,Kohn L,et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin[J].J Invest Dermatol,2002,119(6):1449-1455.DOI:10.1046/j.1523-1747.2002.19617.x.
[12] Xu L,Leng H,Shi X,et al. MiR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis[J].Biomed Pharmacother,2017,90:524-530.DOI:10.1016/j.biopha.2017.03.105.
[13] Yang R,Yao L,Fang Y,et al. The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density:a systematic review and meta-analysis of cohort studies[J].J Bone Miner Metab,2018,36(2):209-220.DOI:10.1007/s00774-017-0828-5.
[14] Sun L,Zhu LL,Lu P,et al. Genetic confirmation for a central role for TNFalpha in the direct action of thyroid stimulating hormone on the skeleton[J].Proc Natl Acad Sci U S A,2013,110(24):9891-9896.DOI:10.1073/pnas.1308336110.
[15] Boutin A,Eliseeva E,Gershengorn MC,et al. β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation[J].FASEB J,2014,28(8):3446-3455.DOI:10.1096/fj.14-251124.
[16] Yang C,Lu M,Chen W,et al. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques[J].J Exp Med,2019,216(5):1182-1198.DOI:10.1084/jem.20181473.
[17] Giménez-Barcons M,Colobran R,Gómez-Pau A,et al. Graves' disease TSHR-stimulating antibodies(TSAbs)induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation?[J].J Immunol,2015,194(9):4199-4206.DOI:10.4049/jimmunol.1500183.
[18] Marín-Sánchez A,lvarez-Sierra D,González O,et al. Regulation of TSHR expression in the thyroid and thymus may contribute to TSHR tolerance failure in Graves' disease patients via two distinct mechanisms[J].Front Immunol,2019,10:1695.DOI:10.3389/fimmu.2019.01695.
[19] Latif R,Mezei M,Morshed SA,et al. A modifying autoantigen in Graves' disease[J].Endocrinology,2019,160(5):1008-1020.DOI:10.1210/en.2018-01048.
[20] Rocha A,Gómez A,Galay-Burgos M,et al. Molecular characterization and seasonal changes in gonadal expression of a thyrotropin receptor in the European sea bass[J].Gen Comp Endocrinol,2007,152(1):89-101.DOI:10.1016/j.ygcen.2007.03.001.
[21] Sun SC,Hsu PJ,Wu FJ,et al. Thyrostimulin,but not thyroid-stimulating hormone(TSH),acts as a paracrine regulator to activate the TSH receptor in mammalian ovary[J].J Biol Chem,2010,285(6):3758-3765.DOI:10.1074/jbc.M109.066266.
[22] Lyu J,Imachi H,Yoshimoto T,et al. Thyroid stimulating hormone stimulates the expression of glucose transporter 2 via its receptor in pancreatic beta cell line,INS-1 cells[J].Sci Rep,2018,8(1):1986.DOI:10.1038/s41598-018-20449-3.

相似文献/References:

[1]陈宁,朱云娟,陈慧,等.TSHR胞外区中间段在BALB/c小鼠体内的免疫原性研究[J].国际内分泌代谢杂志,2007,(04):267.
[2]孟淑华,魏军平.TSHR信号转导通路在Graves眼病发病机制中的作用[J].国际内分泌代谢杂志,2014,(02):84.[doi:10.3760/cma.j.issn.1673-4157.2014.02.004]
　Meng Shuhua,Wei Junping..Roles of TSHR signal transduction pathway in Graves' ophthalmopathy[J].International Journal of Endocrinology and Metabolism,2014,(01):84.[doi:10.3760/cma.j.issn.1673-4157.2014.02.004]

备注/Memo

备注/Memo:
通信作者:罗佐杰,Email:zluo888@163.com
更新日期/Last Update: 2021-01-20